Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.77 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL722087 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL16289663 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL4257733 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL4335281 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL2411393 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL3092973 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL466711 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL18140350 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL18140847 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB | |
| Glycerin SCHEMBL10277135 | 1.00 | USP2 (0.77) | USP2HTTMEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4051239-A1 | POLOXAMER COMPOSITIONS WITH REDUCED SOL-GEL TRANSITION TEMPERATURES AND METHODS OF REDUCING THE SOL-GEL TRANSITION TEMPERATURE OF POLOXAMER COMPOSITIONS | Rochal Technologies LLC (US) | 2022-09-07 | — | — | EP | claimed |
| CN-114929200-A | Method for lowering sol-gel transition temperature | 罗查尔科技有限责任公司 | 2022-08-19 | — | — | CN | claimed |
| WO-2021086698-A1 | METHODS FOR REDUCING THE TEMPERATURE OF SOL-GEL TRANSITIONS | ROCHAL INDUSTRIES, LLC (US) | 2021-05-06 | — | — | WO | claimed |
| US-20210121575-A1 | Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions | ROCHAL INDUSTRIES, LLC (US) | 2021-04-29 | — | — | US | claimed |
| US-20090130029-A1 | GLYCEROL ETHERS VEHICLE AND PHARMACEUTICAL COMPOSITIONS THEREOF | FOAMIX LTD. (IL) | 2009-05-21 | — | — | US | claimed |
| EP-4051239-A1 | POLOXAMER COMPOSITIONS WITH REDUCED SOL-GEL TRANSITION TEMPERATURES AND METHODS OF REDUCING THE SOL-GEL TRANSITION TEMPERATURE OF POLOXAMER COMPOSITIONS | Rochal Technologies LLC (US) | 2022-09-07 | — | — | EP | disclosed |
| CN-114929200-A | Method for lowering sol-gel transition temperature | 罗查尔科技有限责任公司 | 2022-08-19 | — | — | CN | disclosed |
| WO-2021086698-A1 | METHODS FOR REDUCING THE TEMPERATURE OF SOL-GEL TRANSITIONS | ROCHAL INDUSTRIES, LLC (US) | 2021-05-06 | — | — | WO | disclosed |
| US-20210121575-A1 | Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions | ROCHAL INDUSTRIES, LLC (US) | 2021-04-29 | — | — | US | disclosed |
| US-10428194-B2 | Modified acrylic resin cured product, and laminate thereof, and production methods therefor | MITSUI CHEMICALS, INC. (JP) | 2019-10-01 | — | — | US | disclosed |
| EP-3263635-B1 | MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR | MITSUI CHEMICALS INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-20180163056-A1 | HYDROPHILIC CURABLE COMPOSITIONS | MITSUI CHEMICALS, INC. (JP) | 2018-06-14 | — | — | US | disclosed |
| EP-0593897-B1 | Stabilized solutions of alkylphosphocholine in glycerolalkylether | ASTA MEDICA AG (DE) | 1996-04-17 | — | — | EP | disclosed |
| EP-0533213-B1 | Use of azelastin and glycerine ethers for the treatment of psoriasis | ASTA MEDICA AG (DE) | 1994-09-21 | — | — | EP | disclosed |
| EP-0593897-A1 | Stabilized solutions of alkylphosphocholine in glycerolalkylether | ASTA Medica Aktiengesellschaft (DE) | 1994-04-27 | — | — | EP | disclosed |
| US-5290769-A | Applying compositions for skin disorders | ASTA PHARMA AKTIENGESELLSCHAFT (DE) | 1994-03-01 | — | — | US | disclosed |
| EP-0533213-A1 | Use of azelastin and glycerine ethers for the treatment of psoriasis | ASTA Medica Aktiengesellschaft (DE) | 1993-03-24 | — | — | EP | disclosed |
| US-5110814-A | Antiinflammatory agents; ulcerative colitis | ASTA PHARMA AG (DE) | 1992-05-05 | — | — | US | disclosed |
| EP-0419998-A2 | Use of alkylphosphonic acid derivatives for the treatment of psoriasis | ASTA Medica Aktiengesellschaft (DE) | 1991-04-03 | — | — | EP | disclosed |
| EP-0378086-A2 | Use of the agent azelastine in the treatment of psoriasis | ASTA Medica Aktiengesellschaft (DE) | 1990-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210121575-A1 | Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions | PAOX, HPGDS, SPTSSB | USP2 706/4885HTT 2356/4885MEN1 3789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.